Indrayani Biotech Ltd to Hold Meeting to Approve Proposed Rights Issue Details
Indrayani Biotech Ltd announced that its Rights Issue Committee will convene on Thursday, April 09, 2026. The meeting is scheduled to consider and approve details regarding the company's proposed partly paid-up Rights Issue.The Committee's objective during the session is to finalize key parameters for the proposed rights issue. These details include determining the total number of Rights Equity Shares to be issued to meet the desired issue size.
Furthermore, the Committee will fix several other parameters crucial to the offering. These parameters encompass the Rights Issue Price, the Rights Entitlement Ratio, the duration of the Rights Issue period, and the Record Date designated to identify eligible shareholders.
In addition to the rights issue parameters, the Committee will also formalize the appointment of two key service providers. The appointments concern the Monitoring Agency and the Banker to the Issue, who will be tasked with managing fund flows and ensuring compliance.
Stock Price Movement
On Monday, Indrayani Biotech Ltd settled at ₹8.10, posting a loss of 1.94%. Shares traversed a notable intraday band, ranging from a low of ₹7.60 up to a high of ₹8.40.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.